Intersect ENT (XENT) Tops Q3 EPS by 5c

Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $17.84 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal
• Barclays Upgrades United Internet AG (UTDI:GR) (UDIRY) to Overweight